Dolby Laboratories (DLB)

Cash ratio

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash and cash equivalents US$ in thousands 701,893 698,566 626,551 520,821 577,752 741,636 709,535 656,816 745,364 765,079 688,443 626,158 620,127 858,905 900,393 1,056,690 1,225,380 1,219,650 1,104,570 1,110,020
Short-term investments US$ in thousands 703 763 — — 0 127,321 115,863 140,823 139,148 124,210 126,393 132,875 189,213 156,812 141,688 80,618 38,839 48,277 58,582 52,261
Total current liabilities US$ in thousands 437,790 388,785 457,485 441,877 417,836 354,536 442,902 394,096 422,226 423,036 314,011 290,447 277,518 285,485 280,959 283,290 315,717 308,965 308,977 316,419
Cash ratio 1.60 1.80 1.37 1.18 1.38 2.45 1.86 2.02 2.09 2.10 2.59 2.61 2.92 3.56 3.71 4.01 4.00 4.10 3.76 3.67

September 30, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($701,893K + $703K) ÷ $437,790K
= 1.60